All the news Showing 10 of 645 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatocellular carcinoma (HCC) Ramucirumab targeted therapy extends liver cancer survival Liz Highleyman / 09 July 2018 Ramucirumab (Cyramza), a type of targeted therapy that slows tumour growth by blocking blood vessel formation, led to improved overall survival and delayed disease progression in people with hepatocellular carcinoma ... Diagnosis and monitoring New simplified scoring system identifies people with hepatitis B in need of treatment in Africa Keith Alcorn / 02 July 2018 Liver enzyme and hepatitis B 'e' antigen test results are sufficient to determine which people with hepatitis B need antiviral treatment for the infection in sub-Saharan Africa, a study carried ... NAFLD Mixed results for experimental therapies for NASH Liz Highleyman / 22 June 2018 The recent International Liver Congress in Paris featured several presentations on investigational therapies for fatty liver disease. Drugs with a range of different mechanisms – including the thyroid hormone receptor agonist MGL-3196, ... Treatment outcomes Over 300,000 people waiting for hepatitis C treatment in the United States Keith Alcorn / 20 June 2018 At least 300,000 people were awaiting treatment for hepatitis C by the end of 2016 in the United States, with the lowest rates of treatment observed in the Upper Midwest, ... Treatment outcomes Fatty liver improves rapidly after hepatitis C cure Michael Carter / 18 June 2018 Liver stiffness and liver fat (steatosis) in people with chronic hepatitis C virus (HCV) infection both improve significantly after treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR), ... Harm reduction interventions and policy Scotland’s reduction in new HCV infections due to harm reduction, not treatment Keith Alcorn / 12 June 2018 The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and ... Prisoners Harm reduction measures for HCV prevention and treatment lacking in Europe's prisons, survey finds Keith Alcorn / 31 May 2018 Harm reduction measures for the prevention and treatment of hepatitis C in prisoners are still lacking in the majority of European countries and the lack of harm reduction will block ... Prisoners Access to testing and treatment for hepatitis C in European prisons must improve Keith Alcorn / 30 May 2018 Lack of access to hepatitis C treatment and prevention in European prisons is a public health emergency and risks breaching international agreements on the avoidance of inhumane and degrading conditions, ... Hepatitis C elimination Georgia: 98% cured of hepatitis C Keith Alcorn / 23 May 2018 Georgia is making strong progress towards eliminating hepatitis C but will need triple the number of people starting treatment if it is to reach its national elimination target of a ... Hepatocellular carcinoma (HCC) T cell immunotherapy shows promise for treating liver cancer Liz Highleyman / 22 May 2018 Personalised immunotherapy reduces the risk of liver cancer recurrence and may lead to tumour regression, according to a pair of studies presented at the 2018 International Liver Congress last month in Paris. In ... ← First12345...65Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds